These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15192437)

  • 1. Lipolytic PPAR activation: new insights into the intersection of triglycerides and inflammation?
    Ziouzenkova O; Plutzky J
    Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):369-75. PubMed ID: 15192437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
    Latruffe N; Vamecq J
    Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisomes in cardiomyocytes and the peroxisome / peroxisome proliferator-activated receptor-loop.
    Colasante C; Chen J; Ahlemeyer B; Baumgart-Vogt E
    Thromb Haemost; 2015 Mar; 113(3):452-63. PubMed ID: 25608554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual roles for lipolysis and oxidation in peroxisome proliferation-activator receptor responses to electronegative low density lipoprotein.
    Ziouzenkova O; Asatryan L; Sahady D; Orasanu G; Perrey S; Cutak B; Hassell T; Akiyama TE; Berger JP; Sevanian A; Plutzky J
    J Biol Chem; 2003 Oct; 278(41):39874-81. PubMed ID: 12878589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATGL-mediated triglyceride turnover and the regulation of mitochondrial capacity in skeletal muscle.
    Meex RC; Hoy AJ; Mason RM; Martin SD; McGee SL; Bruce CR; Watt MJ
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(11):E960-70. PubMed ID: 25852007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease.
    Tontonoz P; Nagy L
    Curr Opin Lipidol; 1999 Dec; 10(6):485-90. PubMed ID: 10680041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
    Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J
    J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Evaluation of Gemcabene and Peroxisome Proliferator-Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease.
    Bisgaier CL; Oniciu DC; Srivastava RAK
    J Cardiovasc Pharmacol; 2018 Jul; 72(1):3-10. PubMed ID: 29621036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptors and the control of fatty acid oxidation in cardiac hypertrophy.
    Planavila A; Calvo RR; Vázquez-Carrera M
    Mini Rev Med Chem; 2006 Mar; 6(3):357-63. PubMed ID: 16515475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function.
    Chinetti G; Fruchart JC; Staels B
    Curr Opin Lipidol; 2003 Oct; 14(5):459-68. PubMed ID: 14501584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR alpha, fibrates, lipid metabolism and inflammation.
    Duval C; Fruchart JC; Staels B
    Arch Mal Coeur Vaiss; 2004 Jun; 97(6):665-72. PubMed ID: 15283041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARs: fatty acid sensors controlling metabolism.
    Poulsen Ll; Siersbæk M; Mandrup S
    Semin Cell Dev Biol; 2012 Aug; 23(6):631-9. PubMed ID: 22273692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis.
    Neve BP; Fruchart JC; Staels B
    Biochem Pharmacol; 2000 Oct; 60(8):1245-50. PubMed ID: 11007963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.
    Plutzky J
    Curr Atheroscler Rep; 2000 Jul; 2(4):327-35. PubMed ID: 11122762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptors and inflammation.
    Moraes LA; Piqueras L; Bishop-Bailey D
    Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitro-fatty acids as novel electrophilic ligands for peroxisome proliferator-activated receptors.
    Ferreira AM; Minarrieta L; Lamas Bervejillo M; Rubbo H
    Free Radic Biol Med; 2012 Nov; 53(9):1654-63. PubMed ID: 22982052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peroxisome proliferator-activated receptors under epigenetic control in placental metabolism and fetal development.
    Lendvai Á; Deutsch MJ; Plösch T; Ensenauer R
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E797-810. PubMed ID: 26860983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice.
    Tanaka S; Yamamoto H; Nakahashi O; Kagawa T; Ishiguro M; Masuda M; Kozai M; Ikeda S; Taketani Y; Takeda E
    Nutr Res; 2013 Jul; 33(7):586-93. PubMed ID: 23827134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression?
    Puddu P; Puddu GM; Muscari A
    Int J Cardiol; 2003 Aug; 90(2-3):133-40. PubMed ID: 12957742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.